BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34296619)

  • 1. First-in-Class Cyclic Temporin L Analogue: Design, Synthesis, and Antimicrobial Assessment.
    Bellavita R; Casciaro B; Di Maro S; Brancaccio D; Carotenuto A; Falanga A; Cappiello F; Buommino E; Galdiero S; Novellino E; Grossmann TN; Mangoni ML; Merlino F; Grieco P
    J Med Chem; 2021 Aug; 64(15):11675-11694. PubMed ID: 34296619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycine-replaced derivatives of [Pro
    Merlino F; Carotenuto A; Casciaro B; Martora F; Loffredo MR; Di Grazia A; Yousif AM; Brancaccio D; Palomba L; Novellino E; Galdiero M; Iovene MR; Mangoni ML; Grieco P
    Eur J Med Chem; 2017 Oct; 139():750-761. PubMed ID: 28863356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
    Gou S; Li B; Ouyang X; Ba Z; Zhong C; Zhang T; Chang L; Zhu Y; Zhang J; Zhu N; Zhang Y; Liu H; Ni J
    J Med Chem; 2021 Aug; 64(15):11247-11266. PubMed ID: 34180670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel temporin L antimicrobial peptides: promoting self-assembling by lipidic tags to tackle superbugs.
    Bellavita R; Falanga A; Buommino E; Merlino F; Casciaro B; Cappiello F; Mangoni ML; Novellino E; Catania MR; Paolillo R; Grieco P; Galdieroa S
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1751-1764. PubMed ID: 32957844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents.
    Tzitzilis A; Boura-Theodorou A; Michail V; Papadopoulos S; Krikorian D; Lekka ME; Koukkou AI; Sakarellos-Daitsiotis M; Panou-Pomonis E
    J Pept Sci; 2020 Jul; 26(7):e3254. PubMed ID: 32567085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship, conformational and biological studies of temporin L analogues.
    Mangoni ML; Carotenuto A; Auriemma L; Saviello MR; Campiglia P; Gomez-Monterrey I; Malfi S; Marcellini L; Barra D; Novellino E; Grieco P
    J Med Chem; 2011 Mar; 54(5):1298-307. PubMed ID: 21319749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective total synthesis of a novel regiomer of herbarumin I and its cytotoxic and antimicrobial activities.
    Jangili P; Kashanna J; Kumar CG; Poornachandra Y; Das B
    Bioorg Med Chem Lett; 2014 Jan; 24(1):325-7. PubMed ID: 24300737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of new N-terminal fatty acid modified-antimicrobial peptide analogues with potent in vitro biological activity.
    Zhong C; Liu T; Gou S; He Y; Zhu N; Zhu Y; Wang L; Liu H; Zhang Y; Yao J; Ni J
    Eur J Med Chem; 2019 Nov; 182():111636. PubMed ID: 31466017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-cancer, immunoregulatory, and antimicrobial activities of the frog skin host-defense peptides pseudhymenochirin-1Pb and pseudhymenochirin-2Pa.
    Mechkarska M; Attoub S; Sulaiman S; Pantic J; Lukic ML; Conlon JM
    Regul Pept; 2014 Nov; 194-195():69-76. PubMed ID: 25447194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of topologically distinct constrained antimicrobial peptides with broad-spectrum antimicrobial activity.
    Yuan F; Tian Y; Qin W; Li J; Yang D; Zhao B; Yin F; Li Z
    Org Biomol Chem; 2018 Aug; 16(32):5764-5770. PubMed ID: 30004546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disulfide engineering on temporin-SHf: Stabilizing the bioactive conformation of an ultra-short antimicrobial peptide.
    Dolle A; Nagati VB; Hunashal Y; Krishnamurthy K; Pasupulati AK; Raghothama S; Gowd KH
    Chem Biol Drug Des; 2019 Sep; 94(3):1634-1646. PubMed ID: 30924306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effects and cell selectivity of temporin-1CEa, an antimicrobial peptide from the skin secretions of the Chinese brown frog (Rana chensinensis).
    Wang C; Li HB; Li S; Tian LL; Shang DJ
    Biochimie; 2012 Feb; 94(2):434-41. PubMed ID: 21871946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and anti-tumor activities of novel Brevinin-1BYa peptidomimetics.
    Xiong S; Wang N; Liu C; Shen H; Qu Z; Zhu L; Bai X; Hu HG; Cong W; Zhao L
    Bioorg Med Chem Lett; 2021 Apr; 37():127831. PubMed ID: 33556573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a Novel Antimicrobial Peptide, Temporin-PKE, from the Skin Secretion of
    Lin Y; Jiang Y; Zhao Z; Lu Y; Xi X; Ma C; Chen X; Zhou M; Chen T; Shaw C; Wang L
    Biomolecules; 2022 May; 12(6):. PubMed ID: 35740884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain.
    Diao Y; Han W; Zhao H; Zhu S; Liu X; Feng X; Gu J; Yao C; Liu S; Sun C; Pan F
    J Pept Sci; 2012 Jul; 18(7):476-86. PubMed ID: 22641352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrocarbon stapled temporin-L analogue as potential antibacterial and antiendotoxin agents with enhanced protease stability.
    Mahto AK; Kanupriya ; Kumari S; Yar MS; Dewangan RP
    Bioorg Chem; 2024 Apr; 145():107239. PubMed ID: 38428282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LL-37-derived short antimicrobial peptide KR-12-a5 and its d-amino acid substituted analogs with cell selectivity, anti-biofilm activity, synergistic effect with conventional antibiotics, and anti-inflammatory activity.
    Kim EY; Rajasekaran G; Shin SY
    Eur J Med Chem; 2017 Aug; 136():428-441. PubMed ID: 28525841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Tachyplesin Peptides and Their Cyclized Analogues to Improve Antimicrobial and Anticancer Properties.
    Vernen F; Harvey PJ; Dias SA; Veiga AS; Huang YH; Craik DJ; Lawrence N; Troeira Henriques S
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31455019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial and anti-inflammatory activity of a temporin B peptide analogue on an in vitro model of cystic fibrosis.
    Bezzerri V; Avitabile C; Dechecchi MC; Lampronti I; Borgatti M; Montagner G; Cabrini G; Gambari R; Romanelli A
    J Pept Sci; 2014 Oct; 20(10):822-30. PubMed ID: 25201563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa.
    Yang QZ; Wang C; Lang L; Zhou Y; Wang H; Shang DJ
    Arch Pharm Res; 2013 Nov; 36(11):1302-10. PubMed ID: 23609760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.